Apollo agrees $2.6bn Aspen deal

BY Richard Summerfield

Investment funds associated with Apollo Global Management have agreed to acquire Aspen Insurance Holdings Ltd in an all-cash transaction valued at $2.6bn.

The deal, which has been approved by Aspen’s board of directors, will see the Apollo Funds acquire all of the outstanding shares of Aspen for $42.75 per share in cash. The transaction is expected to close in the first half of 2019, subject to the approval of regulators and Aspen’s shareholders, as well as the satisfaction of other closing conditions. The funds are paying around a 7 percent premium to Aspen’s closing share price on the day before the deal was announced.

“We are tremendously excited for the Apollo Funds to acquire Aspen,” said Alex Humphreys, a partner at Apollo. “We believe that Aspen benefits from strong underwriting talent, specialized expertise and longstanding client relationships which makes them well positioned in the market. We look forward to working with Aspen to build on the existing high quality specialty insurance and reinsurance business and we aim to leverage Apollo’s resources and deep expertise in financial services to support the company as it embarks on its next chapter.”

“We are delighted to have reached this agreement with the Apollo Funds,” said Glyn Jones, chairman of Aspen’s board of directors. “This transaction, which is the outcome of a thorough strategic review by Aspen’s board of directors, provides shareholders with immediate value and will allow Aspen to work with an investor that has substantial expertise and a successful track record in the (re)insurance industry.”

“This transaction is a testament to the strength of Aspen’s franchise, the quality of our business and the talent and expertise of our people,” said Chris O’Kane, Aspen’s chief executive. “Under the ownership of the Apollo Funds, Aspen will have additional scale and access to Apollo’s investment and strategic guidance, which will help us to accelerate our strategy and take Aspen to the next level. We are excited about the future as we embark on a new chapter in our history with a partner that understands our strengths, culture and customer-centric philosophy.”

Aspen has been up for sale for some time and Apollo has long been touted as a potential acquirer for the company. Aspen reported a loss of about $15m in the second quarter of 2018, continuing its run of poor financial returns. The company has suffered losses in three out of the last four quarters, having been adversely affected by hurricanes, wildfires and earthquakes.

News: Apollo Agrees to Acquire Aspen Insurance for $2.6 Billion

Santos to acquire Quadrant for $2.15bn

BY Richard Summerfield

Santos Ltd, Australia’s second largest independent oil & gas producer, is to acquire privately held Quadrant Energy for at least $2.15bn.

The deal will provide Santos with a strong boost to its domestic natural gas offering as it will gain access to Quadrant’s 80 percent stake in the Dorado oil field, which Quadrant’s partner Carnarvon Petroleum recently called a “truly incredible” oil discovery. The field has been found to have around 171 million barrels of oil, making it one of the biggest discoveries in the region for around 30 years as well as one of the largest oil resources ever found on the North West Shelf.

Under the terms of the deal, Santos has agreed a $2.15bn base price for Quadrant; however, the company has agreed to pay $50m for certified resources of 100 million barrels for the Dorado field, and then $2 a barrel extra for reserves of between 100 million and 125 million barrels, and $2.50 a barrel for reserves above 125 million.

“This acquisition delivers increased ownership and operatorship of a high-quality portfolio of low cost, long-life conventional Western Australian natural gas assets which are well known to Santos, and importantly significantly strengthens Santos’ offshore operating capability,” said Kevin Gallagher, managing director of Santos. “It is materially value-accretive for Santos shareholders and advances Santos’ aim to be Australia’s leading domestic natural gas supplier.”

“We have delivered operational excellence, outstanding results in our exploration program and successfully integrated an entire new business model throughout the company,” said Brett Darley, chief executive of Quadrant. “All of this has been achieved with a strong focus on the environment, and the commitment to the health and safety of our people.

“On behalf of Quadrant Energy I would like to say how pleased I am to be part of this agreement with Santos and our business and people are well placed for this exciting new chapter as part of a national and international oil and gas producer.”

The deal for Quadrant, which is 36 percent owned by Brookfield Asset Management Inc and 22 percent by Macquarie Group Ltd, will be funded via existing cash resources and new debt facilities.

According to a statement from Santos, the two companies’ assets overlap in Western Australia, providing synergies estimated at $30m to $50m a year.

News: Australia's Santos expands with $2.15 billion Quadrant buy after spurning takeover

M&A market booms

BY Richard Summerfield

The global M&A market is booming with average deal sizes climbing in the first half of the year, according to Pitchbook’s ‘2Q 2018 Global M&A Report’.

“The M&A market is inexorably linked with business sentiment, corporate fundamentals and macroeconomic forces,” said Wylie Fernyhough, an analyst at PitchBook. “With all these indicators continuing to trend positively, the global M&A boom shows no signs of stopping and the announced deals should ensure M&A activity continues to flourish throughout the rest of the year.”

In Q2, across the US and Europe there were 4735 completed deals totalling $987.8bn in value, a decline of 2 percent and an increase of 24 percent respectively, over the first quarter of 2018. Q1 saw 4823 deals worth $799.7bn. The mega-merger market remained strong in H1, with 31 deals recorded worth in excess of $5bn. Vodafone's $21.8bn purchase of UPC Czech was one of five deals above $10bn which closed in Q2 and which caused a rise in average deal value.

In total, across Europe, there were 3424 transactions completed totalling $569.7bn, compared to 5336 deals valued at $797.8bn achieved in the same period last year. Despite this decline, European M&A has not yet suffered the prophesised negative effects of Brexit.

Thirteen mega-deals were closed in 2018, five of which were in the UK, including announced deals such as Takeda’s bid for Shire worth $62bn and the ongoing $34bn tug of war between Fox and Comcast for Sky. North America saw 5213 deals completed, worth $1 trillion.

The financial services sector saw deal value fall in H1 2018, however, as fewer large deals closed. The sector saw 790 completed transactions with a total value of $161.5bn, down from 960 deals with a value of $227.6bn in the first half of 2017. Regardless of the slow start to 2018, the sector did see two notable deals in Q2, including the $3bn acquisition of Pure Industrial by Blackstone and Ivanhoé Cambridge.

One of the key deal drivers going forward may be the ongoing shift in global interest rates. In North America rates have risen, whereas in the eurozone rate rises may still be a year away. As a result, many companies may be pushing through acquisitions in the short term in order to secure more attractive financing before rates rises potentially derail transactions, making them financially unattractive.

Report: 2Q 2018 Global M&A Report

Starwood clinches GE asset deal

BY Richard Summerfield

GE Capital has agreed to sell its GE Energy Financial Services’ Project Finance Debt Business to Starwood Property Trust for $2.56bn, including $400m of unfunded loan commitments.

The business includes a platform and leadership team, along with 21 full-time employees working on loan origination, underwriting, capital markets and asset management. The transaction, which is expected to close in Q3 2018, will, Starwood believes, boost the company’s core earnings.

The deal will see Starwood expand beyond the real estate industry after seven years of unsuccessfully attempting to diversify. GE, by contrast, is in the midst of an effort to divest its assets and refocusing its efforts on power plants and renewable energy. Thus far, the company has raised billions of dollars through asset sales. In June, GE also said it would separate its healthcare unit and sell a stake in Baker Hughes. The company has also agreed to merge its locomotive unit with Wabtec Corp and its industrial gas-engine business to Advent International Corp.

“The sale of the Project Finance Debt Business is aligned to GE Capital’s overall balance sheet reduction efforts and reflects progress against our strategy announced in January 2018,” said Alec Burger, president of GE Capital. “The business is highly complementary to the Starwood Property Trust platform, which has deployed over $44bn of capital since its inception in 2009 and has vast lending experience across diversified assets and geographies.”

“It has been our intention since we began Starwood Property Trust to build a multi-cylinder finance company, with the thought that we should never overstay our welcome in any one business line and always have opportunities to deploy capital into only those verticals where reward clearly outweighs risk,” said Barry Sternlicht, chairman and chief executive of Starwood Property Trust.

He added: “From our basic and still most important business as one of the nation's largest commercial real estate lenders, we have successfully diversified the company. We have built a world-class conduit lending and CMBS trading platform, bought in excess of $3.5 billion of property assets to yield double digit current returns on equity deployed, and created, from a standing start, a very successful single family lending platform. Today we are pleased to announce we are adding a new cylinder to our Company, with the return on investment profile and ability to scale to be material to our $14 billion enterprise.”

News: Starwood Property to buy part of GE Capital's energy finance unit for $2.56 billion

Leo Pharma acquires Bayer’s prescription dermatology portfolio

BY Fraser Tennant

In a deal intended to bolster its role as a leading global dermatology company and achieve its goal of helping 125 million patients by 2025, multinational Danish pharmaceutical company Leo Pharma has acquired German multinational pharmaceutical and life sciences company Bayer AG’s global prescription dermatology portfolio.

Bayer’s portfolio includes branded topical prescription treatments for acne, fungal skin infections and rosacea, as well as a range of topical steroids with an annual turnover in 2017 of more than €280m. The definitive agreement will enable Leo Pharma to expand significantly in key markets worldwide and broaden its therapeutic areas.

The transaction does not include Bayer's over-the-counter dermatology portfolio of brands.

“We are very excited about this agreement,” said Gitte P. Aabo, president and chief executive of Leo Pharma. “With the strong prescription dermatology brands and new colleagues from Bayer, we will broaden our treatment range and considerably enhance our size in key markets around the world – underlining our ambition to be a preferred partner in medical dermatology.” Approximately 450 people will join Leo Pharma as part of the transaction.

“We are very pleased to have found a good partner in Leo Pharma, which has a long history as a leader in scientific advancement and a culture that values discovery and innovation,” said Heiko Schipper, a member of Bayer’s board of management and president of consumer health. “With the dedicated support of many employees to whom we are grateful, our prescription dermatology business has grown well since becoming part of Bayer AG in 2006.”

The acquisition is expected to close in two steps. First, during 2018 for the US, and second, during the second half of 2019 for all other markets. The transaction is subject to the satisfaction of customary closing conditions, including approval by the competition authorities.

The financial details of the deal have not been disclosed.

Mr Schipper concluded: “Moving forward, we believe that Leo Pharma is the right owner to grow and further the prescription dermatology business, while enabling Bayer to focus on building its core over-the counter brands”.

News: Bayer sells prescription dermatology brands to Denmark's Leo Pharma